Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Vivani Medical, Inc.NASDAQ: VANI
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 33.3% from a year ago
Common stock stood at $8K at the end of Q1 FY2026, up 33.3% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +17.0% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +33.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 8K USD
- Year-over-year change
- +33.3%
- 4-year CAGR
- -89.0%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8K | +33.3% |
| FY2024 | 2024-12-31 | 6K | +20.0% |
| FY2023 | 2023-12-31 | 5K | +0.0% |
| FY2022 | 2022-12-31 | 5K | -100.0% |
| FY2021 | 2021-12-31 | 54.65M | — |
Common Stock vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +33.3% is the 2nd highest of 8, against a peer median of +0.0%.
- Common stock amounts to 0.0% of total assets for VANI, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$213.35M CAD | +19.0% | +22.9% | 677.6% | |
| Mar 2026 | $672K USD | +93.1% | +103.3% | 0.9% | |
| Mar 2026 | $491K USD | +0.0% | -0.3% | 0.2% | |
IMAImageneBio Inc | Mar 2026 | $11K USD | -77.1% | -32.6% | 0.0% |
| Mar 2026 | $10K USD | +25.0% | +12.6% | 0.0% | |
| Mar 2026 | $8K USD | +33.3% | +17.0% | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | -1.7% | 0.0% | |
| Mar 2026 | -$632K USD | -21166.7% | — | 1.2% | |
| Peer median (excluding VANI) | — | +0.0% | +6.2% | 0.2% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.